Metabolomics markers in Neurology: current knowledge and future perspectives for therapeutic targeting.
Roberta BonomoGuido CavalettiDebra Jean SkenePublished in: Expert review of neurotherapeutics (2020)
Elucidation of characteristic metabolic alterations in neurological disorders is crucial for a better understanding of their pathogenesis, and for identifying potential biomarkers and drug targets. Nevertheless, discrepancies in diagnostic criteria, sample handling protocols, and analytical methods still affect the generalizability of current study results.